english.prescrire.org > Prescrire International > N°119 - September 2011

n°119

September 2011

Issue Contents
Editorial

Free  Just who are we working for?

p.200
Amidst pressure from media, advertising and government, time to stop and ask some basic questions

New Products


Indacaterol (New Drug)

p.201-205
A long-acting beta-2 agonist, no advantages in COPD

Aciclovir + hydrocortisone (New Combination)

p.205-207
Herpes labialis: a topical antiviral drug perhaps, but not a steroid

INN common stems: -ciclovir

p.207

Mesalazine (Wording Change)

p.208
Now authorised for children, but no suitable form

Adverse Effects


Skin-lightening cosmetics: frequent, potentially severe adverse effects

p.209-215

Mechanisms of action of skin-lightening products

p.211

Adverse effect profile of common components of skin-lightening cosmetics

p.212-213

Skin-lightening creams: warn women of child-bearing age about the risks

p.214

Reviews


Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only

p.216-219
Always limit the dose and duration of treatment with NSAIDs

Prescrire's advice: rational use of anti-ulcer drugs to prevent serious gastroduodenal adverse effects associated with NSAIDs

p.219

Outlook


Free  Medical ethics and social justice

p.220
Should be part of medical training

Free  Queries and comments. Does Prescrire’s editorial staff have conflicts of interest?

p.221-222
Changing the world but not alone

Free  Prescrire’s Solidarity Support Programme

p.224

Masthead


Free  Masthead

p.198

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe